Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 7Lymphoma, Large B-Cell, Diffuse 4Sarcoma, Ewing 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Sarcoma, Clear Cell 2Rhabdomyosarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neurofibrosarcoma 2Nerve Sheath Neoplasms 2Lymphoma 2Liposarcoma 2Hodgkin Disease 2Histiocytoma, Angiomatoid Fibrous 2Granuloma, Plasma Cell 2Fibrosarcoma 2Dermatofibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Wilms Tumor 1Vascular Neoplasms 1Teratoma 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Pleuropulmonary blastoma 1Perivascular Epithelioid Cell Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms, Adipose Tissue 1

Interventions

Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleuropulmonary blastoma × Ifosfamide × 90 days × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡